Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Necrostatin-5 is a RIP1 kinase inhibitor.1 It inhibits phosphorylation of RIP1 in Jurkat cells when used at concentrations of 10 and 30 µM. Necrostatin-5 inhibits TNF-α-induced necroptosis in Jurkat cells deficient in Fas-associated death domain protein (FADD; EC50 = 0.24 µM), a modification that prevents caspase activation in response to death-domain receptor signaling. It reduces lactate dehydrogenase (LDH) release in S. marcescens-infected MH-S macrophages in a concentration-dependent manner.2 Necrostatin-5 (100 µM, i.p.) improves survival in a mouse model of S. marcescens-induced pneumonia.
WARNING This product is not for human or veterinary use.
1. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4(5), 313-321 (2008).
2. Pore-